The Uttarakhand Food and Drug Administration (FDA) has stated that a factory in Dehradun, which allegedly manufactured the banned drug Captagon, was never registered with the state authorities. This revelation comes after the Narcotics Control Bureau (NCB) uncovered an illegal manufacturing unit during a major operation in Delhi.
Operation Ragepill Uncovers Massive Drug Haul
The NCB conducted a raid in the Neb Sarai area of Delhi under the codename 'Operation Ragepill' and seized a consignment of Captagon pills worth approximately Rs 182 crore. The contraband was traced back to a facility in Dehradun, Uttarakhand, prompting an investigation by the state's FDA.
No Registration Records Found
Upon inspection, the Uttarakhand FDA confirmed that the factory had no valid registration to manufacture any pharmaceutical or narcotic products. Officials stated that the facility was operating illegally and had not been inspected or licensed by the state drug control department. The FDA is now coordinating with the NCB to determine the full extent of the operation.
Captagon, often referred to as a 'jihadi drug', is a synthetic stimulant that has been linked to militant groups in the Middle East. Its production and distribution are strictly prohibited under Indian law. The NCB's seizure is one of the largest in recent years, highlighting the growing challenge of synthetic drug trafficking in the country.
Authorities are investigating whether the Dehradun factory was part of a larger network involved in the production and smuggling of Captagon. Further arrests and seizures are expected as the probe continues.
